P2Y(12) Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model

Current guidelines recommend initiation of a P2Y(12) inhibitor for all patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) at the time of diagnosis (pre-treatment); however, there are no randomized trials directly comparing pre-treatment with initiation at the time of angiography to su...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunton, James, Hartshorne, Trent, Langrish, Jeremy, Chuang, Anthony, Chew, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999792/
https://www.ncbi.nlm.nih.gov/pubmed/27548237
http://dx.doi.org/10.3390/jcm5080072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999792/
https://www.ncbi.nlm.nih.gov/pubmed/27548237
http://dx.doi.org/10.3390/jcm5080072

Ejemplares similares